Technology | Ultrasound Imaging | October 17, 2017

Philips Receives FDA 510(k) Clearance to Market Small Parts Ultrasound Solution

One-transducer solution and tailored clinical tools for 'small parts' ultrasound imaging assess diseases and disorders in one of the fastest growing segments of ultrasound exams

 Philips-MicroFlow-Imaging-testicular-ultrasound
 Philips-eL18-4-PureWave-ultrasound-transducer-thyroid

October 17, 2017 — Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the new eL18-4 transducer with full solution for 'small parts' assessment. These ultrasound exams detect abnormalities in the small organs that are close to the skin. The Philips Ultimate Small Parts Solution features four key innovations that work together to help improve patient care: the eL18-4 PureWave linear array transducer, Philips MicroFlow Imaging, Philips Elastography and Philips Precision Biopsy. The new eL18-4 transducer can also be used to assess musculoskeletal injuries.

Philips will debut this latest solution, which is available on Philips Epiq 7 and 5 and Affiniti 70 ultrasound systems, at the 16th World Federation for Ultrasound in Medicine and Biology (WFUMB) Congress, Oct. 13-17 in Taipei, Taiwan.

Small parts imaging is a rapidly growing segment of ultrasound examinations for clinicians around the world. Its broad set of applications include assessment of diseases and disorders of small organs such as breasts, testicles and thyroid, as well as musculoskeletal injuries like sprains and tears. High-resolution ultrasound, such as that available on Philips Epiq and Affiniti solutions, allows clinicians to visualize and characterize abnormalities and evaluate organ blood flow, guide treatment and perform biopsies of suspicious lesions.

"My clinical experience with the new Philips eL18-4 small parts transducer has enabled excellent versatility and penetration that could easily replace my current transducers," said Lynwood Hammers, DO, Hammers Healthcare Imaging, New Haven, Conn. "I am able to see subtle lesions with great detail and excellent sensitivity for small vessel details. In my opinion, this new small parts transducer definitely elevates my clinical confidence and decreases indeterminate diagnosis."

The Philips Epiq Ultimate Small Parts Solution is comprised of a suite of features for small parts assessment. These include:

  • The Philips eL18-4 transducer allows fine-elevation focusing to deliver exceptional detail resolution and tissue uniformity for clinical solutions, including: thyroid, breast, testicular, musculoskeletal, vascular, bowel, pediatrics and obstetrics;
  • Philips MicroFlow Imaging provides remarkable sensitivity and detail for small vessel blood flow assessment;
  • Complete Elastography solution with both strain and ElastQ Imaging shear wave capability reveals definitive information on tissue stiffness; and
  • New precision biopsy capabilities help minimize needle blind zones and support the ability to enhance the display of needle reflections – all to elevate confidence during interventional procedures.

For more information: www.usa.philips.com/healthcare

Related Content

The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
According to a new...
Previously approved by FDA in the USA, MyLab X8 expands the reach of the MyLab Ultrasound Product Line with a fully featured premium imaging solution, integrating the latest technologies and delivering superior image quality without compromising workflow or efficiency.
News | Ultrasound Imaging | January 20, 2021
January 20, 2021 — Esaote North America announces that the...
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conser
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. #AI #AIhealthcare #AIecho

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

News | Artificial Intelligence | January 06, 2021
January 6, 2021 — The U.S.